A Multi-Center, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Tolerability of the Neutrophil Elastase Inhibitor PHP-303 in Adults with Alpha-1 Antitrypsin Deficiency (AATD)
100 Clinical Results associated with Ph Pharma, Inc.
0 Patents (Medical) associated with Ph Pharma, Inc.
100 Deals associated with Ph Pharma, Inc.
100 Translational Medicine associated with Ph Pharma, Inc.